Cargando…
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
The world raced to develop vaccines to protect against the rapid spread of SARS-CoV-2 infection upon the recognition of COVID-19 as a global pandemic. A broad spectrum of candidates was evaluated, with mRNA-based vaccines emerging as leaders due to how quickly they were available for emergency use w...
Autores principales: | Semple, Sean C., Leone, Robert, Barbosa, Christopher J., Tam, Ying K., Lin, Paulo J. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876479/ https://www.ncbi.nlm.nih.gov/pubmed/35214130 http://dx.doi.org/10.3390/pharmaceutics14020398 |
Ejemplares similares
-
Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery
por: Żak, Magdalena M., et al.
Publicado: (2021) -
Lipid nanoparticles for mRNA delivery
por: Hou, Xucheng, et al.
Publicado: (2021) -
Delivery of mRNA to platelets using lipid nanoparticles
por: Novakowski, S., et al.
Publicado: (2019) -
Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle
por: Yang, Tongren, et al.
Publicado: (2020) -
Ionizable lipid nanoparticles for in utero mRNA delivery
por: Riley, Rachel S., et al.
Publicado: (2021)